Advertisement

SIBN

SI-BONE, Inc.

Healthcare · USD

Set alert

Price alert · SIBN

All alert types
21.23 USD -1.18 -5.27%
As of Oct 30, 2026 Extended hours 21.23 0.00%
Bid
21.23 × 2
Ask
21.25 × 2
20.95 Day range 22.25
11.61 52-week range 22.41
YTD
+7.66%
1 year
+40.13%
Open
22.19
Prev close
22.41
Mkt cap
941.54M
Vol
1.25M
Avg vol
565.76K
EPS
-0.34
P/E
0.00
Div yield
0.00%
More statistics
Low
20.95
High
22.25
Forward P/E
-67.74
Beta
0.66
Short ratio
8.24
Inst. own
109.52%
Dividend
0.00
Ex-div date
Earnings
Aug 5, 2024
50-d avg
19.33
200-d avg
16.36
1y target
25.44

5D chart

Chart tools
Interval
SIBN five-day price chart20.721.321.822.422.9Oct 26Oct 28Oct 29Oct 30

Key statistics

Market cap
993.87M
Enterprise value
875.24M
Trailing P/E
0.00
Forward P/E
-67.74
PEG ratio
0.00
Price / sales
4.65
Price / book
5.49
EPS (TTM)
-0.34
Beta
0.66
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-6.85%
Revenue (TTM)
213.60M
Revenue growth
15.20%
Free cash flow
-861.88K
Total cash
145.94M
Total debt
42.80M
Return on equity
-8.30%
Shares outstanding
44.35M
Short % of float
12.23%
50-day average
19.33
200-day average
16.36

Analyst view

Consensus: none

Price target (mean) 25.44 +19.9% upside
Target (low)
20.00
Target (mean)
25.44
Target (high)
32.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Aug 5, 2024

Expected Aug 5, 2024. Consensus EPS estimate -0.12813.

Earnings history

Financials — quick view

All financials
SIBN Revenue — quarterly 56.01M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SIBN Net income — quarterly -4.09M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SIBN EPS — quarterly -0.09
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SIBN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.22-0.16+0.06+27.27%
Aug 5, 2024Jun 1, 2024-0.26-0.22+0.04+15.38%
Aug 5, 2024Jun 1, 2024-0.26———
May 6, 2024Mar 1, 2024-0.29-0.27+0.02+6.90%
May 6, 2024Mar 1, 2024-0.29———
Feb 26, 2024Dec 1, 2023-0.29-0.27+0.02+6.90%

Upgrades / downgrades

SIBN analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2026Truist SecuritiesmainBuyBuy
Aug 4, 2026UBSmainBuyBuy
Aug 4, 2026Truist SecuritiesreitBuyBuy
Aug 4, 2026TD CowenmainBuyBuy
Jul 28, 2026UBSinit—Buy
Jul 16, 2026Truist SecuritiesmainBuyBuy

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
si-bone.com

News

Your note

Sign in to keep a note on SIBN — it syncs with the Stock Master app.

Insider holders

SIBN insider holders
InsiderRelationLatest transactionDateShares held
DAVIS TIMOTHY E JRDirectorStock Award(Grant)Jun 3, 202676,679
DUNN JEFFREY WDirectorConversion of Exercise of derivative securitySep 30, 202697,130
FRANCIS LAURA A.Chief Executive OfficerSaleOct 11, 20260
FREUND JOHN GORDONDirectorStock Award(Grant)Jun 3, 2026146,025
HILLEMAN JERYL LDirectorStock Award(Grant)Jun 3, 202643,772
HINCKLEY GREGORY KDirectorConversion of Exercise of derivative securityApr 6, 2026180,738

Institution ownership

SIBN institution ownership
Holder% heldSharesValueReported
First Light Asset Management, LLC18.33%8,127,985182.15MJun 29, 2026
Blackrock Inc.8.29%3,676,25982.38MJun 29, 2026
Cadian Capital Management, LP7.55%3,347,57475.02MJun 29, 2026
American Century Companies Inc5.66%2,510,96356.27MJun 29, 2026
Brown Advisory Inc.4.68%2,077,13446.55MJun 29, 2026
Granahan Investment Management LLC4.35%1,931,18243.28MJun 29, 2026

Fund ownership

SIBN fund ownership
Holder% heldSharesValueReported
American Century Mutual Funds, Inc.-Small Cap Growth Fund4.28%1,895,95442.49MJul 30, 2026
IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund3.21%1,425,01031.93MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.01%1,337,04829.96MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.56%1,136,59425.47MSep 29, 2026
First Eagle Funds-First Eagle Small Cap Opportunity Fund1.52%673,47615.09MJul 30, 2026
College Retirement Equities Fd.-College Retirement Equities Fd. - Tota1.30%578,35412.96MJun 29, 2026
Advertisement